Share This Page
Suppliers and packagers for nascobal
✉ Email this page to a colleague
nascobal
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642 | NDA | ENDO USA, Inc. | 49884-270-82 | 4 SPRAY in 1 CARTON (49884-270-82) | 2009-08-13 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: NASCOBAL
Introduction
NascoBal is a pharmaceutical formulation primarily comprising vitamin B12 (cyanocobalamin) aimed at addressing vitamin B12 deficiency. Its clinical applications include treatment of pernicious anemia, peripheral neuropathy, and other neurological disorders linked to B12 deficiency. As a vital medication, manufacturers and suppliers play a crucial role in ensuring drug availability, quality standards, and supply chain resilience. This article offers an in-depth overview of key suppliers for NascoBal, covering manufacturers, regional suppliers, and strategic considerations for procurement.
Understanding NascoBal and its Market Dynamics
NascoBal is often marketed as a branded or generic formulation. The drug's active ingredient, cyanocobalamin, is widely produced and distributed globally. The supply chain is complex, involving raw material suppliers for B12, formulation manufacturers, and distributors. Market demand for vitamin B12 supplements has increased due to rising prevalence of deficiency conditions and an expanding aging population, making the security of supply and quality assurance paramount for stakeholders.
Major Manufacturers of Cyanocobalamin (Active Ingredient for NascoBal)
Given NascoBal’s composition, the uptime and quality of cyanocobalamin supply are pivotal. Several global manufacturers produce pharmaceutical-grade cyanocobalamin, and their capacity often influences NascoBal's availability.
Global Leaders in Cyanocobalamin Production
1. Novo Nordisk
- Overview: Novo Nordisk is a leading biopharmaceutical company with significant production capacity for vitamin B12 formulations, including cyanocobalamin.
- Supply Capabilities: Large-scale manufacturing facilities (Denmark, U.S.) with WHO-GMP certification ensure high-quality raw materials.
- Relevance: Novo Nordisk supplies both bulk cyanocobalamin and finished products, making it a strategic supplier for pharmaceutical companies.
2. Merck KGaA / MilliporeSigma
- Overview: A prominent global manufacturer of pharmaceutical excipients and active ingredients.
- Supply Capabilities: Produces pharmaceutical-grade cyanocobalamin used globally in compounding and manufacturing.
- Reputation: Known for stringent quality control and extensive distribution networks, ensuring reliable supply.
3. Fagron
- Overview: An international supplier of raw materials, including cyanocobalamin, primarily to pharmaceutical compounding markets.
- Supply Capabilities: Provides cyanocobalamin powder suitable for formulation into injectable and oral products.
- Note: Often supplies to regional markets where commercial manufacturing is limited.
4. CordenPharma (a part of the International Chemical Investors Group)
- Overview: Specializes in active pharmaceutical ingredients including cyanocobalamin.
- Supply Capabilities: Offers high-purity cyanocobalamin with customized manufacturing capabilities.
5. Local and Regional Manufacturers
Numerous regional suppliers in markets like India, China, and Eastern Europe produce pharmaceutical-grade cyanocobalamin, catering to local and emerging markets. Examples include:
- Micro Labs (India)
- Shenzhen Chondo Biological Technology Co., Ltd. (China)
- Biochem Pharmaceutical Industries (India)
These regional manufacturers often serve as cost-effective options but require rigorous quality validation.
Key Regional Suppliers and Distributors for NascoBal
While raw material manufacturers supply the active ingredient, finished NascoBal products or formulations are distributed globally through regional pharmaceutical companies, contract manufacturing organizations (CMOs), and authorized distributors.
Regional and Local Suppliers
1. India
- Market Drivers: Large generic drug manufacturing ecosystem, supportive of B12 drug production.
- Major Players: Micro Labs, Biochem Pharmaceutical Industries.
- Supply Role: Produce finished NascoBal formulations and active ingredients for domestic and export markets.
2. China
- Market Drivers: Growing capacity in active pharmaceutical ingredients (APIs).
- Major Manufacturers: Shenzhen Chondo Biological Technology, among others.
- Supply Role: Supply cyanocobalamin raw materials and finished pharmaceutical products.
3. Europe and North America
- Market Drivers: Strict regulatory environment, high-quality standards.
- Major Suppliers: Merck KGaA, Novo Nordisk.
- Supply Role: Focused on high-quality, regulated formulations, and supply of both API and finished products.
Supply Chain and Strategic Considerations
Given the dependency on a limited number of API manufacturers, supply chain security for NascoBal hinges on multiple factors:
- Quality Certification: Ensuring suppliers have WHO-GMP or FDA standards.
- Supply Agreements: Long-term contracts to mitigate shortages.
- Manufacturing Capacity Expansion: Diversification of suppliers to avoid bottlenecks.
- Regional Regulation: Navigating import-export restrictions and compliance issues.
Risks and Mitigation
- Manufacturing Disruptions: Political, environmental, or regulatory issues may impact production.
- Quality Variability: Rigorous supplier qualification processes are crucial.
- Price Fluctuations: Market demand and raw material costs can influence pricing.
Emerging Trends and Future Outlook
The pharmaceutical industry's focus on supply chain resilience, especially post-COVID-19, is reshaping procurement strategies for NascoBal. Increasing local manufacturing, investing in regional API production, and stringent quality audits are emerging as industry standards. Additionally, innovation in B12 derivatives and alternative formulations could diversify supplier dependency.
Key Takeaways
- Global Leaders: Novo Nordisk, Merck KGaA, and CordenPharma are primary suppliers of cyanocobalamin, with regional manufacturers supplementing supply in emerging markets.
- Supply Chain Risk: Dependence on limited API producers necessitates diversified sourcing, quality assurance, and long-term procurement agreements.
- Regional Market Dynamics: Indian and Chinese manufacturers dominate in volume, often providing cost-effective solutions, but require rigorous quality validation.
- Quality and Compliance: Suppliers must adhere to WHO-GMP, FDA, and EMA standards to ensure drug safety and efficacy.
- Strategic Procurement: Companies should evaluate supplier capacity, regulatory status, and geographic diversification to secure reliable NascoBal supply.
FAQs
1. Who are the leading global manufacturers of cyanocobalamin used in NascoBal?
Leading manufacturers include Novo Nordisk, Merck KGaA (MilliporeSigma), and CordenPharma, with regional players in India and China also contributing significantly.
2. How does supply chain diversification impact the availability of NascoBal?
Diversification reduces dependency on single suppliers, mitigates risks of shortages, and ensures consistent drug availability amid geopolitical or regulatory disruptions.
3. What quality standards should suppliers adhere to for NascoBal’s API?
Suppliers should comply with WHO-GMP, FDA, or EMA standards. Certification ensures product purity, safety, and efficacy.
4. Are regional suppliers reliable for large-scale NascoBal production?
Regional suppliers can be reliable if they meet international quality standards. Due diligence, audits, and long-term agreements are essential for assurance.
5. What emerging trends could influence NascoBal suppliers in the future?
Enhanced regional manufacturing, increased regulatory oversight, and innovations in vitamin B12 derivatives are shaping future supply landscape dynamics.
References
- [1] Pharmaceutical APIs: Cyanocobalamin Market Analysis, IQVIA, 2022.
- [2] World Health Organization, Good Manufacturing Practices Guidelines, 2021.
- [3] Industry Reports: “Global Vitamin B12 Market,” MarketsandMarkets, 2022.
- [4] Regulatory Standards: U.S. FDA, EMA, and WHO drug quality guidelines.
- [5] Company Websites: Novo Nordisk, Merck KGaA, CordenPharma.
This comprehensive overview guides stakeholders through the landscape of NascoBal suppliers, emphasizing quality, reliability, and strategic sourcing to ensure medication availability in dynamic markets.
More… ↓
